Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 15 , ISSUE 1 ( January-February, 2023 ) > List of Articles

Original Article

Prevalence of Abnormal Ovarian Masses/Cysts in Sri Lankan Women over 40 Years of Age

Kahandhawa Appuhamillage Madhavi Priyangika Gunathilake, Vindya Kumarapeli, Athula Kaluarachchi, Rajaguru Mudiyanselage Chaminda Bandara Hunukumbure

Keywords : Ovarian cyst, Ovarian mass, Postmenopausal, Premenopausal, Prevalence, Ultrasound assessment

Citation Information : Gunathilake KA, Kumarapeli V, Kaluarachchi A, Hunukumbure RM. Prevalence of Abnormal Ovarian Masses/Cysts in Sri Lankan Women over 40 Years of Age. J South Asian Feder Obs Gynae 2023; 15 (1):19-23.

DOI: 10.5005/jp-journals-10006-2176

License: CC BY-NC 4.0

Published Online: 19-04-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim: For any unsuspecting woman, the finding of an ovarian cyst/mass that has the potential to be either malignant or end up in a cyst accident (torsion, rupture, or hemorrhage) and hence requires intervention, is of paramount importance. Based on ultrasound-guided explicit criteria, this study was aimed at determining the prevalence of abnormal ovarian masses, both malignant and benign, in the most vulnerable age group. Materials and methods: A community-based; descriptive cross-sectional study was conducted among 931 females aged over 40 years who were selected by probability proportionate to the cluster sampling technique. All the study participants underwent trans-abdominal ultrasound scanning. Married subjects were offered a subsequent transvaginal scan (TVS) if indicated. Results: The prevalence of abnormal ovarian masses based on ultrasound assessment was 2.9% [95% confidence interval (CI): 1.8–4.0]. Thirteen subjects (1.4%) had complex cysts between 3 and 5 cm diameter (95% CI: 0.8–2.3) and five (0.53%) had complex cysts larger than 5 cm (95% CI: 0.2%–1.2%). The prevalence of simple ovarian cysts exceeding 5 cm was 0.97% (95% CI: 0.5–1.8). Histopathological examination of abnormal ovarian masses that needed surgery revealed; endometrioma (n = 6), mature cystic teratoma (n = 1), mucinous cyst adenoma (n = 1), serous cyst adenoma (n = 1), and serous papillary cyst adenocarcinoma (n = 1). Conclusion: Abnormal ovarian cysts/masses were more prevalent among women aged above 50 years, and those who had attained menopause. Pelvic ultrasound assessment of women in their 50s belonging to potential high-risk groups can be recommended on an annual basis.


PDF Share
  1. National Cancer Control Programme, Ministry of Health. Cancer Incidence and Mortality Data in Sri Lanka. Sri Lanka Cancer Registry – 21st Publication, 2019. Available at: https://www.nccp.health.gov.lk/storage/post/pdfs/Cancer%20Incidence%20Data%20Book-2019_compressed.pdf. Accessed date: 10 February, 2022.
  2. World Health Organization. South-East Asia (SEARO). International Agency for Research on Cancer. Emergency: Coronavirus disease (COVID-19) pandemic, 2020. Available at: https://www.who.int/southeastasia. Accessed date: 10 February, 2022.
  3. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132(5):1133–1145. DOI: 10.1002/ijc.27711.
  4. van Nagell JR Jr, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened. Cancer 2007;109(9):1887–1896. DOI: 10.1002/cncr.22594.
  5. Behtash N, Rahmani M, Ghotbizadeh F, et al. Ultrasonography and computed tomography for management of adnexal masses in Iranian patients with suspected ovarian cancer: Results of a prospective study. Asian Pac J Cancer Prev 2009;10(2):201–204. PMID: 19537883.
  6. Katiyar S, Arya SB, Goel JK, et al. Sonographic folliculometry and endometrial echocomplex as an evidence of ovulation in infertility cases. 2016;9(4):331–335. DOI:10.5005/jp-journals-10006-1524.
  7. Levine D, Brown DL, Andreotti RF, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of radiologists in ultrasound consensus conference Statement. Radiology. 2010;256(3):943–954. DOI: 10.1148/radiol.10100213.
  8. Modesitt SC, Pavlik EJ, Ueland FR, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstetrics Gynecol 2003;102(3):594–599. DOI: 10.1016/s0029-7844(03) 00670-7.
  9. Ross EK, Kebria M. Incidental ovarian cysts: When to reassure, when to reassess, when to refer. Cleve Clin J Med 2013;80(8):503–514. DOI: 10.3949/ccjm.80a.12155.
  10. Hakim S, Maheshwari S, Bhargava V. A rare combination of omental cyst, ovarian cyst and leiomyoma of uterus. J South Asian Fed Obstet Gynaecol 2010;2:147–148. DOI: 10.5005/jp-journals-10006-1085.
  11. Royal College of Obstetricians and Gynaecologists. Management of ovarian cysts in the postmenopausal women, Green-top Guideline No. 34. 2016. Available at: https://www.rcog.org.uk/media/4v3ncfib/gtg_34.pdf. Accessed date: 4 January, 2019.
  12. Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: A consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000;16(5): 500–505. DOI: 10.1046/j.1469-0705.2000.00287.x.
  13. Sayasneh A, Ekechi C, Ferrara L, et al. The characteristic ultrasound features of specific types of ovarian pathology (review). Int J Oncol 2015;46(2):445–458. DOI: 10.3892/ijo.2014.2764.
  14. Lwanga SK, Lemeshow S, Organization WH. Sample size determination in health studies: A practical manual. World Health Organization, 1991. Available at: https://apps.who.int/iris/bitstream/handle/10665/40062/9241544058_(p1-p22).pdf. Accessed date: 5 May, 2016.
  15. Bennett S, Woods T, Liyanage WM, et al. A simplified general method for cluster–sample surveys of health in developing countries. World Health Stat Q 1991;44(3):98–106. PMID: 1949887.
  16. Bland JM, Peacock JL. Interpreting statistics with confidence. 2002;4(3):176–180. DOI: DOI: 10.1576/toag.2002.4.3.176.
  17. Niazi M, Kamal MM, Malik N, et al. Transabdominal vs transvaginal sonography: Comparison in pelvic pathologies. J Rawalpindi Med Coll 2015;19(3):223–226. Corpus ID: 34096184.
  18. Wan H, Wong DJ, Tang K-K. Incidence, risk factors, and natural history of ovarian cysts in postmenopausal Chinese women: A retrospective cohort study. Hong Kong J Gynaecol Obstet Midwifery 17(2):106–112. https://www.hkjgom.org/sites/default/files/pdf/v17n2-106-incidence.pdf.
  19. Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: A multicenter study in Japan. Int J Gynecol Cancer 2008;18(3):414–420. DOI: 10.1111/j.1525-1438.2007.01035.x.
  20. Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25–40 years old. 1999;13(5):345–350. DOI: 10.1046/j.1469-0705.1999.13050345.x.
  21. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: The prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011;305(22):2295–303. DOI: 10.1001/jama.2011.766.
  22. Menon U, Gentry–Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS). Lancet Oncol 2009;10:327–340. DOI: 10.1016/S1470-2045(09)70026-9.
  23. Andolf E, Jörgensen C. Simple adnexal cysts diagnosed by ultrasound in postmenopausal women. 1988;16(5):301–303. DOI: 10.1002/jcu.1870160504.
  24. DePriest PD, DeSimone CP. Ultrasound screening for the early detection of ovarian cancer. J Clin Oncol 2003;21(Suppl. 10):194s–199s. DOI: 10.1200/jco.2003.02.054.
  25. Greenlee RT, Commins JM, Riley TL, et al. Prevalence, incidence, and natural history of complex ovarian cysts in a cohort of older women. Ann Epidemiol 2013;23:586–587. DOI: 10.1016/j.annepidem.2013.06.036.
  26. Hartage P, Hoover R, McGowan L, et al. Menopause and ovarian cancer. Am J Epidemiol 1988;127(5):990–998. DOI: 10.1093/oxfordjournals.aje.a114902.
  27. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999;181(5 Pt 1):1263–1269. DOI: 10.1016/s0002-9378(99)70120-1.
  28. Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet 2016; 387(10022):945–956. DOI: 10.1016/s0140-6736(15)01224-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.